Actinogen Medical Limited (ATGGF PINK) stock market data APIs
$0.04
0(0%)
as of January 9, 2026
Try our APIs with
free plan!
Actinogen Medical Limited Financial Data Overview
Price chart is built with
Anychart
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Prev. Close
0.04
Open
0.04
High
0.04
Low
0.04
52 wk Range
0.01-0.04
Market Cap
128 M
Shares Outstanding
3 192 M
Revenue
5 490 K
EPS
-0.0004
Beta
1.234
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Actinogen Medical Limited data using free add-ons & libraries
Get Actinogen Medical Limited Fundamental Data
Actinogen Medical Limited Fundamental data includes:
- Net Revenue: 5 490 K
- EBITDA: -15 013 009
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Actinogen Medical Limited News
New
ASX Penny Stocks To Watch In December 2025
As Australian shares experience a modest uptick, following Wall Street's lead, investors are keenly observing the market dynamics influenced by global economic indicators. Amidst these developments, p...
ASX Penny Stocks With Market Caps Up To A$200M
The Australian market is currently experiencing a challenging period, with significant volatility and downturns impacting investor sentiment. In such times, the appeal of penny stocks—often smaller ...
ASX Penny Stocks Under A$100M Market Cap
The Australian market is experiencing a cautious atmosphere, influenced by a technology selloff in the U.S. and recent fluctuations in gold prices. Despite these challenges, investors continue to seek...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
